Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome.

Literature DB >> 14509993

Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome.

Roy Taylor.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2003 PMID： 14509993 PMCID： PMC196432 DOI： 10.1136/bmj.327.7416.681-c

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

5 in total

1. Blood-pressure reduction and cardiovascular risk in HOPE study.

Authors: P Sleight; S Yusuf; J Pogue; R Tsuyuki; R Diaz; J Probstfield
Journal: Lancet Date: 2001 Dec 22-29 Impact factor: 79.321

2. Blood pressure and cardiovascular risk in the HOPE study.

Authors: Ingrid Mühlhauser
Journal: Lancet Date: 2002-06-15 Impact factor: 79.321

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

4. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

Authors: P Svensson; U de Faire; P Sleight; S Yusuf; J Ostergren
Journal: Hypertension Date: 2001-12-01 Impact factor: 10.190

5. Use of ramipril in preventing stroke: double blind randomised trial.

Authors: Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeff Probstfield
Journal: BMJ Date: 2002-03-23

5 in total

4 in total

Conundrum of the HOPE study: time of taking ramipril may account for lack of relation between blood pressure and outcome.

1. Blood-pressure reduction and cardiovascular risk in HOPE study.

2. Blood pressure and cardiovascular risk in the HOPE study.

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

4. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

5. Use of ramipril in preventing stroke: double blind randomised trial.

1. Timing of drug treatment is crucial.

Review 2. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.

Review 3. Strategies for initial management of hypertension.

Review 4. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?